K M Healthcare
Sola, Ahmedabad, Gujarat
GST No.
24APDPK9037K1ZP
TrustSEAL
Verified
Call 08048262775
68% Response Rate
SEND EMAIL
Our Products
»
Anti Cancer Injection
Hepatitis Medicine
Pharmaceutical Tablet
Anti Cancer Medicines
Pharmaceutical Injection
Anticancer Medicine
Anticancer Injectable
Anticancer Capsule
Life Saving Drug
Injection
Anti Cancer Tablet And Injection
Anticancer Medicines
Anti Cancer Injections
pharmaceutical injectables
Tablets
Anticancer Tablet
HIV Medicines
medicine
Kidney Medicine
Bevacizumab Injection
Antineoplastic Drug
antivirus drug
Pharmaceutical Medicine And Injection
Inconel & Incoloy Pipe
Sunitinibmalate Capsules
Lenalidomide
Dabigatran
Harvestor
Antifungal Medicines
Desirox Tablet
Oxaliplatin
Azacitidine Injection
Heptatitis Medicines
Anticancer Drugs
Alimta Injection
Hot Dip Galvanized I Beam
Evermil Tablets
Dacogen 50mg
Daratumumab Injection
Pharmaceutical Tablet & Capsules
Cipcal D3 Cholecalciferol Granules
Forteo Injections
New Items
Home
Introduction
»
Testimonial
Why Us?
Distributor Enquiry Form
Contact Us
Home
»
Our Products
»
Sunitinibmalate Capsules
Wholesale Trader of a wide range of products which include sunitinib malate 12.5.
Sunitinib Malate 12.5
Ask For Price
Product Price :
Get Latest Price
Product Details:
Strength
12.5 mg
Usage/Application
Hospital
Prescription/Non prescription
Prescription
Country of Origin
Made in India
Product Type
Sunitinib Malate 12.5
We are engaged in offering this product to our clients. Our range of all products is widely appreciated by our clients.
Request
Callback
Yes! I am interested
X
Explore More Products
Altraz 1mg Tablet
Get Best Quote
Acalabrutinib 100mg Capsules
Get Best Quote
Emcure Viropil Tablet
Get Best Quote
Rolimus 10 mg Tablets
Get Best Quote
Zoltero 4mg injection
Get Best Quote
Pentasa 500 Mg Mesalazine Tablets
Get Best Quote
View All Products
Reach Us
Kalpesh Kosti (Proprietor)
K M Healthcare
First, FF-12/A, I The Address, Nr Sola Overbridge, Ahmedabad - 380060, Gujarat, India
Get Directions
Call Us
Call Response Rate: 68%
Share Us
Facebook
Twitter
LinkedIn
Send E-mail